摘要 |
<p>The present invention refers to an <Italic>in vitro</Italic> method to detect a cancer of the pancreas, especially a ductal adenocarcinoma of the pancreas, in an individual, to determine the stage or severity of this cancer in an individual or to monitor the effect of therapy administered to an individual with this cancer; to screen for, identify, develop and evaluate the efficacy of therapeutic compounds against this cancer in order to develop new medicinal products, and also agents that inhibit the expression and/or activity of the DDEF2 protein and/or the effects of this expression.</p> |
申请人 |
MEDPLANT GENETICS S.L. |
发明人 |
DEL AMO IRIBARREN, JOKIN;JUNQUERA SANCHEZ-VALLEJO, CORINA;OCHOA GARAY, JORGE;ESCUREDO GARCIA DE GALDEANO, PEDRO;SANTA CRUZ, SIMON;MARTINEZ MARTINEZ, ANTONIO;SIMON BUELA, LAUREANO;ARGUELLES SANCHEZ, MARIA ELADIA;DE LOS TOYOS GONZALEZ, JUAN RAMON;BARNEO SERRA, LUIS |